These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Nucleotide metabolism in cultured T cells and in cells of patients deficient in adenosine deaminase and purine nucleoside phosphorylase. Cohen A; Gudas LJ; Ullman B; Martin DW Ciba Found Symp; 1978; (68):101-14. PubMed ID: 115659 [No Abstract] [Full Text] [Related]
7. Immune cell function and recycling of purines. Giblett ER N Engl J Med; 1976 Dec; 295(24):1375-6. PubMed ID: 824556 [No Abstract] [Full Text] [Related]
8. Two-dimensional thin-layer chromatography for the screening of disorders of purine and pyrimidine metabolism. van Gennip AH; van Noordenburg-Huistra DY; de Bree PK; Wadman SK Clin Chim Acta; 1978 May; 86(1):7-20. PubMed ID: 95907 [TBL] [Abstract][Full Text] [Related]
9. Rapid prenatal diagnosis of adenosine deaminase deficiency and other purine disorders using foetal blood. Simmonds HA; Fairbanks LD; Webster DR; Rodeck CH; Linch DC; Levinsky RJ Biosci Rep; 1983 Jan; 3(1):31-8. PubMed ID: 6839009 [No Abstract] [Full Text] [Related]
10. Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean. Giblett ER Ciba Found Symp; 1978; (68):3-18. PubMed ID: 115664 [No Abstract] [Full Text] [Related]
11. Adenosine deaminase deficiency and severe combined immunodeficiency disease. Thompson LF; Seegmiller JE Adv Enzymol Relat Areas Mol Biol; 1980; 51():167-210. PubMed ID: 6255772 [No Abstract] [Full Text] [Related]
12. Urinary purines and nucleosides in immune deficiencies. Mills GC; Schmalstieg FC; Goldblum RM Ann N Y Acad Sci; 1985; 451():66-77. PubMed ID: 3865574 [No Abstract] [Full Text] [Related]
13. New perspectives in the diagnosis and treatment of adenosine deaminase (ADA) deficiency. Levinsky RJ; Davies EG; Simmonds HA; Webster DR; Adinolfi M Adv Exp Med Biol; 1984; 165 Pt A():33-8. PubMed ID: 6609527 [No Abstract] [Full Text] [Related]
16. Amelioration of neurologic abnormalities after "enzyme replacement" in adenosine deaminase deficiency. Hirschhorn R; Paageorgiou PS; Kesarwala HH; Taft LT N Engl J Med; 1980 Aug; 303(7):377-80. PubMed ID: 6156414 [No Abstract] [Full Text] [Related]
17. Absence of oroticaciduria in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. Simmonds HA; Potter CF; Sahota A; Cameron JS; Webster DR; Becroft DM Clin Exp Immunol; 1978 Oct; 34(1):42-5. PubMed ID: 108039 [TBL] [Abstract][Full Text] [Related]
18. Intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency. Cowan MJ; Martin DW; Wara DW; Ammann AJ Adv Exp Med Biol; 1984; 165 Pt A():39-45. PubMed ID: 6609530 [No Abstract] [Full Text] [Related]
19. Adenosine deaminase activity in a series of 19 patients with the Diamond-Blackfan syndrome. Whitehouse DB; Hopkinson DA; Pilz AJ; Arredondo FX Adv Exp Med Biol; 1986; 195 Pt A():85-92. PubMed ID: 3728189 [No Abstract] [Full Text] [Related]
20. Metabolic findings in a patient with adenosine deaminase deficiency and severe combined immunodeficiency. Carapella-De Luca E; Stegagno M; Lucarelli P; Signoretti A; Imperato C; Wadman SK; Leyva A; Astaldi A Adv Exp Med Biol; 1984; 165 Pt B():159-62. PubMed ID: 6720425 [No Abstract] [Full Text] [Related] [Next] [New Search]